Related Experiment Video

Updated: May 22, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Gene therapy and nasopharyngeal carcinoma

J Hughes1, G Alusi, Y Wang

  • 1Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary, University of London, London, United Kingdom. jonathanphughes@gmail.com

Rhinology
|May 23, 2012
PubMed

Insights

Gene therapy using adenoviruses is an emerging treatment for head and neck cancers. Recent research explores its application in nasopharyngeal carcinoma management, showing promise in clinical and preclinical studies.

Area of Science:

  • Oncology
  • Gene Therapy
  • Virology

Background:

  • The first government-approved adenoviral gene therapy for head and neck cancer was licensed in 2003.
  • A subsequent approval in 2005 involved a replication-selective adenovirus for nasopharyngeal carcinoma, used alongside chemotherapy.

Purpose of the Study:

  • To introduce gene therapy as a novel treatment modality.
  • To review the application of gene therapy in managing nasopharyngeal carcinoma.
  • To examine recent preclinical and clinical research in this area.

Main Methods:

  • Literature review of preclinical research.
  • Analysis of clinical trial data.
  • Examination of adenoviral vector applications in oncology.

Main Results:

  • Adenoviral gene therapy has achieved regulatory approval for specific head and neck cancers.
  • Combination therapy involving adenoviruses shows potential in nasopharyngeal carcinoma treatment.
  • Ongoing research continues to explore the efficacy and safety of gene therapy for these cancers.

Conclusions:

  • Gene therapy represents a significant advancement in cancer treatment.
  • Adenoviruses are a key vector platform for gene therapy in head and neck oncology.
  • Further research is essential to optimize gene therapy strategies for nasopharyngeal carcinoma.

More Related Videos

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...